摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,5-二-叔丁基-4-(甲氧基甲氧基)苯甲醛 | 151166-75-5

中文名称
3,5-二-叔丁基-4-(甲氧基甲氧基)苯甲醛
中文别名
——
英文名称
4-Methoxymethoxy-3,5-di-tert-butylbenzaldehyde
英文别名
3,5-di-tert-butyl-4-(methoxymethoxy)benzaldehyde;3,5-di-tert-butyl-4-methoxymethyloxybenzaldehyde;3,5-di-tert-butyl-4-methoxymethoxybenzaldehyde;3,5-ditert-butyl-4-(methoxymethoxy)benzaldehyde
3,5-二-叔丁基-4-(甲氧基甲氧基)苯甲醛化学式
CAS
151166-75-5
化学式
C17H26O3
mdl
——
分子量
278.392
InChiKey
HVHFIECYXPKWOA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    364.2±42.0 °C(Predicted)
  • 密度:
    0.989±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.6
  • 重原子数:
    20
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.59
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

SDS

SDS:9d9b46c9d8ad7761e1234c6298226dde
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3,5-二-叔丁基-4-(甲氧基甲氧基)苯甲醛 在 palladium on activated charcoal lithium aluminium tetrahydride 、 potassium tert-butylate氢气 作用下, 以 四氢呋喃乙醇 为溶剂, 生成 3-[3,5-Ditert-butyl-4-(methoxymethoxy)phenyl]propan-1-ol
    参考文献:
    名称:
    Development of a new class of potential antiatherosclerosis agents: NO-donor antioxidants
    摘要:
    A new class of NO-donor phenol derivatives is described. The products were obtained by joining appropriate phenols with either nitrooxy or 3-phenylsulfonylfuroxan-4-yloxy moieties. All the compounds proved to inhibit the ferrous salt/ascorbate induced lipidic peroxidation of membrane lipids of rat hepatocytes. They were also capable of dilating rat aorta strips precontracted with phenylephrine. (C) 2004 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2004.10.006
  • 作为产物:
    描述:
    3,5-二叔丁基-4-羟基苯甲醛盐酸 、 sodium hydride 、 对甲苯磺酸 作用下, 以 四氢呋喃N,N-二甲基甲酰胺丙酮 为溶剂, 反应 50.17h, 生成 3,5-二-叔丁基-4-(甲氧基甲氧基)苯甲醛
    参考文献:
    名称:
    Novel Antiarthritic Agents with 1,2-Isothiazolidine-1,1-dioxide (γ-Sultam) Skeleton: Cytokine Suppressive Dual Inhibitors of Cyclooxygenase-2 and 5-Lipoxygenase
    摘要:
    Various 1,2-isotkiazolidine-1,1-dioxide (gamma-sultam) derivatives containing an antioxidant moiety, 2i6-di-tert-butylphenol substituent, were prepared. Some compounds, which have a lower alkyl group at the 2-position of the gamma-sultam skeleton, showed potent inhibitory effects on both cyclooxygenase (COX)-2 and 5-lipoxygenase (5-LO), as well as production of interleukin (IL)-1 in in vitro assays. They also proved to be effective in several animal arthritic models without any ulcerogenic activities. Among these compounds, (E)-(5)-(3,5-di-tert-butyl-4-hydroxybenzyliclene)-2-ethyl-1,2-isothiazolidine-1, (S-2474) was selected as an antiarthritic drug candidate and is now under clinical trials. The structure-activity relationships (SAR) examined and some pharmacological evaluations are described.
    DOI:
    10.1021/jm9906015
  • 作为试剂:
    描述:
    N-乙基1,1-二氧代-异噻唑烷3,5-二-叔丁基-4-(甲氧基甲氧基)苯甲醛3,5-二-叔丁基-4-(甲氧基甲氧基)苯甲醛 作用下, 以55的产率得到[3,5-Ditert-butyl-4-(methoxymethoxy)phenyl]-(2-ethyl-1,1-dioxo-1,2-thiazolidin-5-yl)methanol
    参考文献:
    名称:
    J. Med. Chem. 2000, 43, 2040-2048
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Use of aryl nitrone compounds in methods for treating neuropathic pain
    申请人:——
    公开号:US20020165274A1
    公开(公告)日:2002-11-07
    3,4,5-trisubstituted aryl nitrone compounds having the formula: 1 where R 1 —R 4 are as defined in the specification are useful as therapeutics for neuropathic pain conditions in mammals.
    具有以下公式的3,4,5-三取代芳基亚硝基化合物:其中R1—R4如规范中定义的,对哺乳动物的神经病性疼痛症状具有治疗作用。
  • 3,4,5-trisubstituted aryl nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation
    申请人:Centaur Pharmaceuticals, Inc.
    公开号:US06342523B1
    公开(公告)日:2002-01-29
    Disclosed are 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing such compounds. The 3,4,5-trisubstituted aryl nitrone compounds have the formula: where R1-R4 are as defined in the specification. The disclosed compositions are useful as therapeutics for inflammation-related conditions in mammals, such as arthritis, and as analytical reagents for detecting free radicals.
    揭示了3,4,5-三取代芳基亚硝基化合物及含有这种化合物的药物组合物。3,4,5-三取代芳基亚硝基化合物化学式如下:其中R1-R4如规范中所定义。所披露的组合物可用作治疗哺乳动物炎症相关疾病,如关节炎,以及用作检测自由基的分析试剂
  • Peroxynitrite generation from a NO-releasing nitrobenzene derivative in response to photoirradiation
    作者:Naoya Ieda、Hidehiko Nakagawa、Taeko Horinouchi、Tao Peng、Dan Yang、Hiroki Tsumoto、Takayoshi Suzuki、Kiyoshi Fukuhara、Naoki Miyata
    DOI:10.1039/c1cc11681a
    日期:——
    Photocontrollable ONOO− generation from a nitrobenzene derivative was demonstrated. The designed compound released NO in response to photoirradiation, and the resulting semiquinone reduced molecular oxygen to generate O2˙−; reaction of the two generated ONOO−, as confirmed with an ONOO−fluorescent probe, HKGreen-3.
    证明了从硝基苯生物中能够光控生成ONOO−。所设计的化合物在光照射下释放NO,生成的亚醌将分子氧还原生成O2˙−;这两者的反应生成ONOO−,通过ONOO−荧光探针HKGreen-3得以确认。
  • Benzylidene derivatives
    申请人:Shionogi & Co., Ltd.
    公开号:US05418230A1
    公开(公告)日:1995-05-23
    Benzylidene derivatives having anti-inflammatory activities, are shown by the following formula I: ##STR1## wherein A is -CH.sub.2 - or -CH.sub.2 CH.sub.2 -; B is a bond or -CH.sub.2 -, -CHOH-, -CO-, -O-, or A and B may taken together form -CH=CH-; D is >N- or >CH-; R.sup.1 and R.sup.2 each independently is hydrogen, lower alkyl or lower alkoxy; R.sup.3 is hydrogen, lower alkyl, cycloalkyl, lower alkoxy, arylalkyloxy, heteroarylalkyloxy, lower alkylcarbonyl, arylcarbonyl, substituted or unsubstituted carbamoyl, or a group of the formula: -(CH.sub.2).sub.n -R.sup.4 wherein R.sup.4 is hydrogen, hydroxy, substituted or unsubstituted amino, aryl, heteroaryl, hydroxycarbonyl or lower alkyloxycarbonyl; n is an integer of 0-3.
    具有抗炎活性的苄亚甲基衍生物,其化学式如下:##STR1## 其中,A为-CH.sub.2-或-CH.sub.2 CH.sub.2-;B为键或-CH.sub.2-,-CHOH-,-CO-,-O-,或A和B可共同形成-CH=CH-;D为>N-或>CH-;R.sup.1和R.sup.2各自独立地为氢、低级烷基或低级烷氧基;R.sup.3为氢、低级烷基、环烷基、低级烷氧基、芳基烷氧基、杂芳基烷氧基、低级烷基羰基、芳基羰基、取代或未取代的基甲酰基,或式为-(CH.sub.2).sub.n-R.sup.4的基团,其中R.sup.4为氢、羟基、取代或未取代的基、芳基、杂芳基、羟基羰基或低级烷氧羰基;n为0-3的整数。
  • Antioxidant Activity of Hydroxystilbene Derivatives in Homogeneous Solution
    作者:Riccardo Amorati、Marco Lucarini、Veronica Mugnaini、Gian Franco Pedulli、Marinella Roberti、Daniela Pizzirani
    DOI:10.1021/jo0497860
    日期:2004.10.1
    The antioxidant activity of the cis and trans isomers of several analogues of resveratrol and pterostilbene has been investigated, especially with regard to the effect of the stereochemistry about the olefinic double bond. The antioxidant power of these compounds was estimated by measuring the rate constants for their reactions with peroxyl radicals and, with two of them, the bond dissociation enthalpy
    已经研究了白藜芦醇萜类萜的几种类似物的顺式和反式异构体的抗氧化活性,特别是关于烯烃双键的立体化学的影响。这些化合物的抗氧化能力是通过测量它们与过氧自由基以及与其中两个自由基在抑制反应中裂解的O-H键的键离解焓(BDE)的反应速率常数来估算的。目前的数据表明,在均相溶液中,所研究的各种羟基丁苯醚均表现为温和的抗氧化剂,但4和6的反式异构体明显例外,其活性仅略低于α-生育酚维生素E)的活性。抑制反应的速率常数表明,在所有检查的情况下,顺式-羟基sti的抗氧化活性比相应的反式异构体差2至6倍。这种较低的反应性取决于焓因素,因为它可以通过O-H键离解焓的实验值中的3' ,5'-二-两个几何异构体来推断叔-丁基4'-羟基-3,5-二甲氧基苯乙烯表明,顺式异构体中的O-H键强度大1.8 kcal / mol。DFT计算提供了该结果的合理性,表明,尽管顺式几何结构暗示了相对于苯氧基自由基和母体羟基
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫